Life Science Product News

Bio-Plex Pro RBM human, rat, and canine kidney toxicity panels, developed in partnership with Myriad RBM, Inc., enable earlier quantitation of FDA-approved markers of acute and chronic kidney injury in clinical and preclinical settings with unprecedented sensitivity.

Bio-Rad has completed the acquisition of AbD Serotec, a leading antibody manufacturer offering over 15,000 antibodies, kits, and accessories. This acquisition will accelerate future antibody development and enhance product offerings in diagnostics and life science research.

Bio-Rad will present a new and improved workflow for the evaluation of antibodies used to measure residual host cell protein impurities in biotherapeutics at the Well Characterized Biotechnology Pharmaceutical Symposium in Washington, D.C. January 29–31.

Professor Alec Morley (Flinders University, Australia), a pioneer in digital PCR, has chosen Bio-Rad Laboratories’ QX100 Droplet Digital PCR system to develop a diagnostic test for chronic myeloid leukemia (CML). Monoquant, the company started by Morley to develop this technology, is seeking FDA approval for its new test.

Bio-Rad’s new S3 cell sorter will be shown at the American Society for Cell Biology (ASCB) Annual Meeting in San Francisco, December 15–19. The S3 cell sorter is an automated, easy-to-use, benchtop cell sorter equipped with one or two lasers, forward and side scatter detectors, and up to four fluorescent detectors.

In a recently published study in Translational Medicine, researchers at Stanford University demonstrated the superiority of the QX100™ Droplet Digital PCR (ddPCR™) system over qPCR for copy number analysis of cancer genome amplifications in FFPE tissue samples.

A retail version of this kit, one of the most popular products offered by the company’s life science education program, introduces consumers to molecular biology by allowing them to extract their own DNA and bottle it as a necklace charm.

The USDA FSIS approved Bio-Rad’s iQ-Check^® real-time PCR method for the detection of six newly regulated Shiga toxin–producing Escherichia coli (STEC) strains in beef, which the FSIS began testing for in June 2012.

The CFX qualification plate is preloaded with an optimized master mix, providing a fast, easy, and accurate method for obtaining pass/fail instrument performance results for all CFX real-time PCR systems.

Designed and validated for detecting up to five targets in reaction volumes between 10 and 125 µl, the CFX96 Touch Deep Well system offers precise quantification and excellent uniformity with high thermal performance.